Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_assertion type Assertion NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_head.
- NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_assertion description "[Women with a heterozygous genotype had no greater risk whereas those with a homozygous variant genotype had a greater risk than women with a wild-type genotype for the MDM2 SNP309 (covariate-adjusted odds ratio, 1.87; 95% confidence interval, 1.29-2.73) for endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_provenance.
- NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_assertion evidence source_evidence_literature NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_provenance.
- NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_assertion SIO_000772 18398041 NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_provenance.
- NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_assertion wasDerivedFrom befree-20140225 NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_provenance.
- NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_assertion wasGeneratedBy ECO_0000203 NP484254.RAl9-FbEgtGZX7tZctRxiS1wbtqlTAUpnd9ngpJpCsEZ4130_provenance.